Cargando…
Human Multi-Chimeric Cell (HMCC) Therapy as a Novel Approach for Tolerance Induction in Transplantation
Cellular therapies are regarded as the most promising approach for inducing transplant tolerance without life-long immunosuppression in solid organ and vascularized composite allotransplantation (VCA). Currently, no therapies are achieving this goal. This study introduces a novel Human Multi-Chimeri...
Autores principales: | Siemionow, Maria, Cwykiel, Joanna, Brodowska, Sonia, Chambily, Lucile |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661767/ https://www.ncbi.nlm.nih.gov/pubmed/37603137 http://dx.doi.org/10.1007/s12015-023-10608-z |
Ejemplares similares
-
Novel Human Umbilical Di-Chimeric (HUDC) cell therapy for transplantation without life-long immunosuppression
por: Siemionow, Maria, et al.
Publicado: (2023) -
Creation of human hematopoietic chimeric cell (HHCC) line as a novel strategy for tolerance induction in transplantation
por: Siemionow, Maria, et al.
Publicado: (2022) -
Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy
por: Siemionow, Maria, et al.
Publicado: (2019) -
Application of Human Epineural Conduit Supported with Human Mesenchymal Stem Cells as a Novel Therapy for Enhancement of Nerve Gap Regeneration
por: Siemionow, Maria, et al.
Publicado: (2021) -
Donor Recipient Chimeric Cells Induce Chimerism and Extend Survival of Vascularized Composite Allografts
por: Cwykiel, Joanna, et al.
Publicado: (2021)